Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

109806-71-5Cetirizine EP Impurity G (Free Base)

● Auf Lager

Katalog-Nr.::	VE006557
CAS-Nr.::	109806-71-5
Summenformel::	C19H23ClN2O
Molare Masse::	330.85 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 109806-71-5

Parent drug

Cetirizine

IUPAC-Name

(RS)-2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethan-1-ol

Pharmakopöe-Synonyme

Cetirizine Related Compound G; Cetirizine Ethanol Impurity

Other Synonyms

2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethanol; 4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol

SMILES

C1CN(CCN1CCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl

InChI

InChI=1S/C19H23ClN2O/c20-18-8-6-17(7-9-18)19(16-4-2-1-3-5-16)22-12-10-21(11-13-22)14-15-23/h1-9,19,23H,10-15H2

Beschreibung

Cetirizine EP impurity G also known as Cetirizine Related Compound G ;Cetirizine Ethanol Impurity, in various pharmacopoeias, is a highly characterized standard. It meets strict regulatory requirements set by USP, EMA, JP, and BP, making it a crucial component in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Cetirizine.